Category: Research

Early nicotinamide use reduces risk of aggressive skin cancers

Importance:  Nicotinamide supplementation has been studied as a chemopreventive medication for reducing skin cancer risk, but large-scale data are limited. Objective: To determine the clinical effica…

Read more about 'Early nicotinamide use reduces risk of aggressive skin cancers'...


Interlaboratory variability of SPF results is considerable and likely greater than expected

Objective: Determination of the sunburn protection provided by a sunscreen product is required globally for sales of these products. Over the past 80 years, many aspects of determining the protection…

Read more about 'Interlaboratory variability of SPF results is considerable and likely greater than expected'...


Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective

Cancer systemic therapeutics and radiotherapy are often associated with dermatological  toxicities that may reduce patients’ quality of life and impact their course of cancer treatment. These toxiciti…

Read more about ' Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective'...


Pre- and post-treatment care for actinic keratoses: An Australian and New Zealand perspective

Background: Actinic keratoses (AKs), also known as solar keratoses, are precancerous skin lesions that typically occur following long-term exposure to ultraviolet radiation. AKs can evolve into cutane…

Read more about ' Pre- and post-treatment care for actinic keratoses: An Australian and New Zealand perspective'...


Cutaneous melanoma management — Update and narrative review for the General Surgeon

Background and Aims: The multidisciplinary management of cutaneous melanoma is advancing rapidly. Surgeons remain a key entry point for melanoma patients into specialist care and their up-to-date kno…

Read more about 'Cutaneous melanoma management — Update and narrative review for the General Surgeon'...


Dynamic recurrence risk prediction tool for adjuvant therapy in stage III melanoma empowering informed decision-making

Background: Prognosis for AJCC stage III melanoma varies significantly. Adjuvant therapies, including pembrolizumab, nivolumab, and dabrafenib/trametinib, have markedly reduced recurrence risk, as sho…

Read more about 'Dynamic recurrence risk prediction tool for adjuvant therapy in stage III melanoma empowering informed decision-making'...


Regular sunscreen users may need supplementary vitamin D

Background: Sunscreen reduces vitamin D production in experimental studies. It is uncertain whether this translates to ‘real-world’ settings. Objectives: We aimed to dtermine if routinely applying hi…

Read more about 'Regular sunscreen users may need supplementary vitamin D'...


Is wide local excision after primary excision of melanoma in situ unnecessary?

Dessinioti and coauthors1 present a retrospective study undertaken in Greece reporting the clinical outcomes for 401 people diagnosed and treated for melanoma in situ from 1991 to 2023 at a major mela…

Read more about 'Is wide local excision after primary excision of melanoma in situ unnecessary?'...


Sentinel lymph node biopsy review: historical trajectory, current guidelines and controversies, future directions

Sentinel lymph node biopsy (SLNB) has transformed the management of cutaneous melanoma, emerging as a cornerstone in evaluating regional lymphatic spread while minimizing surgical morbidity. From its …

Read more about 'Sentinel lymph node biopsy review: historical trajectory, current guidelines and controversies, future directions'...


Higher serum 25(OH)D levels associated with increased skin cancer risk, likely reflecting cumulative UV exposure

Background and objectives: Skin cancer, the most common global malignancy, is linked to ultraviolet (UV)-driven serum 25-hydroxyvitamin D (25(OH)D)synthesis, with its controversial role possibly refle…

Read more about 'Higher serum 25(OH)D levels associated with increased skin cancer risk, likely reflecting cumulative UV exposure'...